i2O Therapeutics snags $4m seed

Allston, Massachusetts-based i2O Therapeutics, a developer of a platform for oral delivery of traditionally injectable biological drugs, has raised $4 million in seed funding.

9 April 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles